Pdt Partners, LLC Nektar Therapeutics Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.03 - $4.28 $112,187 - $236,534	-55,265 Reduced 17.95%	252,688 $571,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $1.59 Million - $2.7 Million	-524,554 Reduced 63.01%	307,953 $985,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $569,560 - $1.11 Million	179,672 Added 27.52%	832,507 $3.16 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $2.24 Million - $7.37 Million	537,523 Added 466.15%	652,835 $3.52 Million
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $127,469 - $216,685	-11,770 Reduced 9.26%	115,312 $1.56 Million
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $547,397 - $789,056	-41,882 Reduced 24.79%	127,082 $2.28 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $81,740 - $100,939	4,948 Added 3.02%	168,964 $2.9 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $327,606 - $503,675	-19,783 Reduced 10.76%	164,016 $3.28 Million
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $136,173 - $164,324	8,635 Added 4.93%	183,799 $3.13 Million
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $180,913 - $270,334	-10,905 Reduced 5.86%	175,164 $2.91 Million
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $2.3 Million - $3.2 Million	-136,709 Reduced 42.35%	186,069 $4.31 Million
Q1 2020 May 15, 2020	SELL	$14.47 - $27.96 $1.15 Million - $2.22 Million	-79,486 Reduced 19.76%	322,778 $5.76 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $795,087 - $1.16 Million	-50,100 Reduced 11.08%	402,264 $8.68 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $3.84 Million - $8.23 Million	226,800 Added 100.55%	452,364 $8.24 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $6.99 Million - $8.19 Million	225,564 New	225,564 $8.03 Million

Others Institutions Holding NKTR

# of Institutions

145

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$14.5 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$13.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$11.9 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$8.55 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$8.37 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $171M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account